Dr Fong Lai Yen
Funding in UTAR
- asiatic acid improves endothelial barrier function via inhibition of vcam-1 and oxidative stress, UTARRF, July 2017 - June 2018.
- interaction of camellia sinensis with p-glycoprotein transport system and its impact on nadolol
pharmacokinetics in hypertensive animal model, UTARRF, September 2018 - August 2019.
- investigation of the effects of asiatic acid on pre-lesional atherogenic events in vitro and atherosclerotic lesion formation in vivo, MOHE FRGS, January 2019 - December 2020.
- evaluation of maslinic acid treatment efficacy in nsg mice with colorectal cancer xenografts and transcriptomics profiling, MOHE FRGS, January 2019 - December 2020.
- evaluation of effects of alternanthera sessilis ethanol extract on tnf-α-induced oxidative stress and endothelial dysfunction on human aortic endothelial cells, UTARRF, August 2020 - January 2022.
- investigation of effect of asiatic acid on plasma lipid profile and
proinflammatory markers in high-fat-diet-fed apoe-deficient
mice, UTARRF, July 2021 - June 2022.
- effects of epigallocatechin-3-gallate in restoration of insulin resistance, hyperglycaemia and dyslipidaemia in a rodent model, UTARRF, December 2021 - December 2022.
- evaluation of effect of a new xanthone derivative, 3-phenylbutylxanthone, on tnf-alpha-induced endothelial activation, UTARRF, July 2022 - June 2023.
Funding not in UTAR
- investigation of roles of rhoa and rock as potential therapeutic targets in interferon-γ-induced
disruption of human umbilical vein endothelial cells (huvecs) barrier function, MOHE FRGS, September 2021 - August 2023.
- unraveling the potential of malaysian tualang honey in combating pathogenesis of atherosclerosis initiated by vascular smooth muscle cells: the mechanisms in vitro and in vivo, MOHE FRGS, November 2020 - October 2023.